Renal Response In Patients With Relapsed Refractory Multiple Myeloma: Interim Data Of A Large, Observational, Prospective Study

Javier De La Rubia,Queralt Salas,Enrique Morales,Esther Gonzalez,Maria Soledad Duran,Fernando Escalante,Mercedes Gironella,Toms Jose Gonzalez-Lopez,Rafael Duro,Manuel Perez,Paz Ribas,Elena Cabezudo,Rafael Lluch,Ignacio Espanol,Valentin Cabanas,Ricardo Garcia-Munoz,Jose Antonio Marquez,Marta Duran,Javier Soriano,Antoni Garcia

BLOOD（2016）

引用 0|浏览23

暂无评分

摘要

Introduction:Renal impairment (RI) is a common complication of multiple myeloma (MM). Almost 20% of patients (pts) present with RI at diagnosis, while approximately 40%-50% of pts will develop RI during the course of their disease. However, there is little information on the renal response of pts with relapsed refractory MM (RRMM) receiving treatment with new drugs in clinical practice.

查看译文

关键词

relapsed refractory multiple myeloma,multiple myeloma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要